Heart Disease Trial, Recruiting NCT07255469 Sponsor: University Hospital, Bordeaux Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07255469
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 15 years old or younger
  • Children who are staying in a pediatric intensive care unit after heart surgery
  • Children whose doctor has ordered a fluid expansion (a specific amount of fluid given through a drip) of 10ml per kilogram of body weight
  • Children whose doctor has ordered blood tests from an artery and a vein before and after the fluid is given, to help manage a serious circulation problem
  • Children who already have a working arterial line in place (a thin tube inserted into an artery to monitor blood pressure and take blood samples)
  • Children who already have a working central venous line in place in the upper chest area (a thin tube inserted into a large vein near the heart)

Who may not be able to join:

  • Babies born prematurely who have not yet reached 37 weeks of corrected age (confirm with trial site)
  • Children whose circulation is too unstable to safely allow any delay for testing
  • Children for whom lying flat on their back is not safe or could cause harm
  • Children where ultrasound imaging of the heart is not possible, either because of poor image quality or because the child is too restless to remain still during the scan
  • Children, parents, or legal guardians who have expressed they do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julien GOTCHAC, MD, CHU de Bordeaux - Hôpital Cardiologique Haut Lévêque

Phone: +33 5 24 54 92 19

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 March 2025
Est. completion
21 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Area under the ROC curve (AUROC, %) of baseline Pv-aCO2/DAVO2 ratio to diagnose metabolic fluid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov